Meta-Analysis of Clinical Evaluation of Anlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer
-
Published:2023
Issue:01
Volume:13
Page:26-33
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Subject
General Engineering
Reference18 articles.
1. 张家豪, 张亚杰, 李鹤成. 2020年V1版《NCCN非小细胞肺癌临床实践指南》更新解读[J]. 中国胸心血管外科临床杂志, 2020, 27(6): 1-5.
2. Cancer statistics, 2018
3. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: Are patients undertreated?
4. Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
5. 皇甫娟, 李文永, 张慧辉. 安罗替尼胶囊治疗晚期非小细胞肺癌对患者VEGF水平及生存期的影响[J]. 实用癌症杂志, 2020, 35(3): 360-362.